(19)
(11) EP 1 032 389 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.05.2008 Bulletin 2008/22

(45) Mention of the grant of the patent:
01.08.2007 Bulletin 2007/31

(21) Application number: 98930358.1

(22) Date of filing: 17.06.1998
(51) International Patent Classification (IPC): 
A61K 31/445(2006.01)
A61P 25/00(2006.01)
(86) International application number:
PCT/US1998/012676
(87) International publication number:
WO 1999/016439 (08.04.1999 Gazette 1999/14)

(54)

CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE

CHRONISCHE BOLUSGABE VON D-THREO METHYLPHENIDAT

ADMINISTRATION DE LONGUE DUREE EN BOLUS DE D-THREO METHYLPHENIDATE


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 29.09.1997 US 937684

(43) Date of publication of application:
06.09.2000 Bulletin 2000/36

(60) Divisional application:
07014078.5 / 1844777

(73) Proprietor: CELGENE CORPORATION
Summit, NJ 07901 (US)

(72) Inventors:
  • DARIANI, Maghsoud, M.
    Fanwood, NJ 07023 (US)
  • ZEITLIN, Andrew, L.
    Millington, NJ 07946 (US)
  • ZELDIS, Jerome, B.
    Princeton, NJ 08540 (US)

(74) Representative: Hallybone, Huw George et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)


(56) References cited: : 
WO-A-97/03671
WO-A-97/03673
US-A- 5 733 756
WO-A-97/03672
WO-A-99/03471
US-A- 5 773 478
   
  • PATRICK K S ET AL: "PHARMACOLOGY OF THE ENANTIOMERS OF THREO-METHYLPHENIDATE" JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND, US, vol. 241, no. 1, 1 April 1987 (1987-04-01), pages 152-158, XP000602302 ISSN: 0022-3565
  • AOYAMA T ET AL: "PHARMACOKINETICS AND PHARMACODYNAMICS OF (+)-THREO-METHYLPHENIDATE ENANTIOMER IN PATIENTS WITH HYPERSOMNIA" CLINICAL PHARMACOLOGY & THERAPEUTICS, MOSBY-YEAR BOOK, ST LOUIS, MO, US, vol. 55, no. 3, 1 March 1994 (1994-03-01), pages 270-276, XP000602459 ISSN: 0009-9236
  • SRINIVAS, N.R., ET AL.: "Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder." CLINICAL PHARMACOLOGY AND THERAPEUTICS, vol. 52, 1992, pages 561-568, XP001073547
  • ECKERMAN, D.A., ET AL.: "Enantioselective behavioral effects of threo-methylphenidate in rats." PHARMACOLOGY BIOCHEMISTRY & BEHAVIOR, vol. 40, 1991, pages 875-880, XP001073568
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).